Methysym

Methylphenidate Hydrochloride, the active ingredient in Methysym, is a central nervous system stimulant presented as a tablet for oral use. It treats attention deficit hyperactivity disorder and narcolepsy in children and adults. GNH USA supplies Methysym as a licensed, GDP-compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Methysym is a central nervous system stimulant indicated for the following conditions:

- Attention deficit hyperactivity disorder (children): improves focus, reduces hyperactivity and impulsivity. - Attention deficit hyperactivity disorder (adults): enhances concentration and executive function. - Narcolepsy: decreases excessive daytime sleepiness and improves wakefulness.

Methylphenidate may cause a range of adverse reactions. Commonly reported events include:

Common Side Effects: - Insomnia: difficulty falling or staying asleep. - Decreased appetite: reduced hunger leading to weight loss. - Headache: mild to moderate cranial pain. - Abdominal discomfort: stomach pain or nausea. - Increased heart rate: mild tachycardia. - Anxiety: heightened nervousness or restlessness.

Serious or Rare Side Effects: - Cardiovascular events: hypertension, arrhythmia, or myocardial infarction. - Psychiatric symptoms: psychosis, mania, or severe agitation. - Severe allergic reaction: rash, swelling, or anaphylaxis. - Seizures: rare occurrence of convulsive episodes. - Growth suppression: notable reduction in height or weight gain in children.

Before initiating therapy with Methysym, consider the following precautions:

- Cardiovascular assessment: evaluate history of heart disease, hypertension, or arrhythmias. - Psychiatric monitoring: watch for new or worsening mood disorders, psychosis, or aggression. - Growth monitoring: regularly assess height and weight in pediatric patients. - Abuse potential: use only as prescribed due to risk of dependence. - Pregnancy and lactation: discuss potential risks with a healthcare professional before use. - Store at ambient temperature: keep in the original container, protect from moisture and heat.

Methylphenidate can interact with several medication classes. Review the following interaction categories:

Major Interactions (Avoid): - Monoamine oxidase inhibitors (MAOIs): risk of hypertensive crisis. - Sympathomimetic agents (e.g., ephedrine): may cause severe hypertension.

Moderate Interactions (Monitor Closely): - Antidepressants (tricyclics, SSRIs): may increase plasma levels of methylphenidate. - Antihypertensive drugs: potential reduction in blood pressure control. - Antacids: may affect absorption and bioavailability.